Xopenex Hfa Aerosol, Metered
Product Images NDC 27437-056

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Xopenex Hfa (NDC 27437-056). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Xop04 0024 01a)

Chemical structure diagram showing the molecular structure of levalbuterol tartrate, the active ingredient in XOPENEX HFA inhalation aerosol. The illustration displays the detailed chemical bonds and groups of the levalbuterol and tartrate components.*

FDA Label Image

Figure 1 (Xop04 0024 02a)

A line graph labeled 'Day 1' showing mean percentage change in FEV1 over a 6-hour period. The graph compares three groups: Xopenex HFA Inhalation Aerosol, Racemic Albuterol HFA 180 mcg, and Placebo, with FEV1 changes plotted on the vertical axis and time in hours on the horizontal axis.*

FDA Label Image

Figure 1 (Xop04 0024 03a)

A line graph titled 'Day 56' showing mean percentage change in FEV1 over time (hours) for three groups: Xopenex HFA Inhalation Aerosol, Racemic Albuterol HFA 180 mcg, and Placebo. The graph compares lung function changes over a 6-hour period following treatment.*

FDA Label Image

Figure 1 (Xop04 0024 04a)

An instructional diagram of XOPENEX HFA aerosol inhaler showing a side view labeling parts including canister, actuator, mouthpiece, and cap, and a top view highlighting the dose indicator with display window, pointer, press area, and targeting rings.*

FDA Label Image

Figure 2a (Xop04 0024 05a)

An illustration showing a dose counter dial with numeric markings, highlighting numbers 80 and 200. The central pointer indicates the remaining doses in the inhaler. This is typically used to show how many doses remain in a metered dose inhaler like XOPENEX HFA.*

FDA Label Image

Figure 2b (Xop04 0024 06a)

An illustration showing a circular dial with an arrow pointer between the numbers 180 and 200, indicating a range likely related to a meter or counter, possibly representing dose counts for the XOPENEX HFA aerosol inhaler.*

FDA Label Image

Figure 2c (Xop04 0024 07a)

An illustration showing a circular dose counter dial with markings at 20, 50, 60, and 180 indicating the number of doses remaining in a metered aerosol inhaler for XOPENEX HFA (levalbuterol tartrate) 45 mcg aerosol. The dial is designed to help users track remaining doses.*

FDA Label Image

Figure 2d (Xop04 0024 08a)

An illustration showing a dose counter for a metered dose inhaler with numbered increments at 0, 20, and 40 doses. The indicator is currently pointing near 20 doses remaining.*

FDA Label Image

Figure 3 (Xop04 0024 09a)

An illustration showing hands holding an inhaler device and removing or replacing its protective cap. The drawing emphasizes the proper handling of the aerosol inhaler, which corresponds to the XOPENEX HFA levalbuterol tartrate metered-dose inhaler.*

FDA Label Image

Figure 4 (Xop04 0024 10a)

An instructional illustration showing a person holding an aerosol metered-dose inhaler. The image depicts the proper way to remove the cap by pulling it off and to prepare the inhaler for use by shaking it as indicated by arrows.*

FDA Label Image

Figure 5 (Xop04 0024 11a)

An instructional illustration showing a person holding an aerosol inhaler device near their mouth. The person is pressing down on the top of the inhaler to release the aerosol spray toward their open mouth, demonstrating the correct technique for inhaling the medication.*

FDA Label Image

Figure 6 (Xop04 0024 12a)

An instructional illustration showing a person holding a metered-dose inhaler near their mouth. The image depicts the proper positioning and use of the inhaler for oral administration, with arrows indicating the direction of inhalation while using the device.*

FDA Label Image

Figure 7 (Xop04 0024 13a)

An instructional diagram showing a person using a metered-dose inhaler labeled XOPENEX HFA. The illustration indicates positioning the finger on the center of the targeting rings while the mouth is placed around the inhaler mouthpiece, demonstrating proper inhaler use technique.*

FDA Label Image

Figure 8 (Xop04 0024 14a)

A black-and-white line drawing showing a hand holding a XOPENEX HFA metered-dose inhaler with a spacer device attached, positioned over a sink faucet. An opened container with a mouthpiece cover is placed nearby on the counter. The illustration likely demonstrates assembly or preparation of the levalbuterol tartrate aerosol inhaler.*

FDA Label Image

Figure 9 (Xop04 0024 15a)

An instructional line drawing showing hands removing the canister from the plastic actuator of a metered dose inhaler, indicated by an upward arrow.*

FDA Label Image

Figure 10 (Xop04 0024 16a)

Instructional line drawing showing a hand holding an inhaler with a mouthpiece cover being washed under a faucet. The sequence demonstrates rinsing and water draining from the inhaler's mouthpiece cover, indicating cleaning steps for the aerosol inhaler device.*

FDA Label Image

Figure 11 (Xop04 0024 17a)

Instructional illustration showing correct finger placement on the center of targeting rings of an inhaler. The top image demonstrates a properly functioning spray labeled 'NOT CLOGGED,' and the bottom image shows an obstructed spray labeled 'CLOGGED.'*

FDA Label Image

Principal Display Panel – Trade Canister Label – 45 Mcg 200 Actuations (Xopenex Canister)

Label for Xopenex HFA inhalation aerosol by Lupin Pharmaceuticals, Inc. Contains levalbuterol tartrate at 45 mcg per actuation in a metered dose aerosol format. The package includes 200 actuations with a net content of 15 g and instructions for oral inhalation use. The label details warnings, storage instructions, and manufacturer information.*

FDA Label Image

Principal Display Panel – Trade Carton (45 MCG 200 ACTUATIONS)

Packaging label for XOPENEX HFA (levalbuterol tartrate) Inhalation Aerosol, 45 mcg per actuation, by Lupin Pharmaceuticals, Inc. The label indicates 200 metered inhalations per container for oral inhalation use with the Xopenex HFA actuator only. The label includes usage warnings, pharmacist instructions, storage information, and manufacturer details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.